PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Adaptive Biotechnologies Corporation (ADPT)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISINUS00650F1093
CUSIP00650F109
SectorHealthcare
IndustryBiotechnology

Highlights

Market Cap$624.84M
EPS (TTM)-$1.49
PE Ratio80.57
Total Revenue (TTM)$125.58M
Gross Profit (TTM)$63.17M
EBITDA (TTM)-$130.53M
Year Range$2.28 - $8.51
Target Price$6.60
Short %10.58%
Short Ratio7.31

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Adaptive Biotechnologies Corporation

Popular comparisons: ADPT vs. SPY

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Adaptive Biotechnologies Corporation, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-100.00%-50.00%0.00%50.00%100.00%FebruaryMarchAprilMayJuneJuly
-89.65%
85.55%
ADPT (Adaptive Biotechnologies Corporation)
Benchmark (^GSPC)

S&P 500

Returns By Period

Adaptive Biotechnologies Corporation had a return of -14.90% year-to-date (YTD) and -46.88% in the last 12 months.


PeriodReturnBenchmark
Year-To-Date-14.90%13.78%
1 month26.75%-0.38%
6 months0.97%11.47%
1 year-46.88%18.82%
5 years (annualized)-36.36%12.44%
10 years (annualized)N/A10.64%

Monthly Returns

The table below presents the monthly returns of ADPT, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2024-25.10%11.99%-21.90%-18.38%31.68%4.93%-14.90%
202321.34%-7.77%3.27%-19.14%-2.52%-3.59%25.78%-19.79%-19.50%-18.53%-1.35%11.87%-35.86%
2022-37.85%-17.26%-3.81%-40.56%-5.21%3.45%13.23%-2.62%-20.18%9.27%12.85%-12.98%-72.77%
2021-6.19%1.98%-28.83%3.33%-9.11%8.07%-10.28%-0.93%-6.42%-1.71%-21.91%7.55%-52.55%
2020-0.05%-6.04%-1.14%15.23%20.90%25.01%-22.86%11.50%16.87%-5.24%4.64%22.63%97.63%
201919.85%-20.19%31.91%-39.23%-15.65%4.32%10.04%-25.76%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of ADPT is 22, indicating that it is in the bottom 22% of stocks on our website in terms of risk-adjusted performance. This ranking is based on the combined values of the indicators listed below.


The Risk-Adjusted Performance Rank of ADPT is 2222
ADPT (Adaptive Biotechnologies Corporation)
The Sharpe Ratio Rank of ADPT is 1818Sharpe Ratio Rank
The Sortino Ratio Rank of ADPT is 2121Sortino Ratio Rank
The Omega Ratio Rank of ADPT is 2323Omega Ratio Rank
The Calmar Ratio Rank of ADPT is 2020Calmar Ratio Rank
The Martin Ratio Rank of ADPT is 2727Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Adaptive Biotechnologies Corporation (ADPT) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


ADPT
Sharpe ratio
The chart of Sharpe ratio for ADPT, currently valued at -0.59, compared to the broader market-2.00-1.000.001.002.003.00-0.59
Sortino ratio
The chart of Sortino ratio for ADPT, currently valued at -0.60, compared to the broader market-4.00-2.000.002.004.00-0.60
Omega ratio
The chart of Omega ratio for ADPT, currently valued at 0.93, compared to the broader market0.501.001.502.000.93
Calmar ratio
The chart of Calmar ratio for ADPT, currently valued at -0.48, compared to the broader market0.001.002.003.004.005.00-0.48
Martin ratio
The chart of Martin ratio for ADPT, currently valued at -0.92, compared to the broader market-30.00-20.00-10.000.0010.0020.00-0.92
^GSPC
Sharpe ratio
The chart of Sharpe ratio for ^GSPC, currently valued at 1.66, compared to the broader market-2.00-1.000.001.002.003.001.66
Sortino ratio
The chart of Sortino ratio for ^GSPC, currently valued at 2.33, compared to the broader market-4.00-2.000.002.004.002.33
Omega ratio
The chart of Omega ratio for ^GSPC, currently valued at 1.29, compared to the broader market0.501.001.502.001.29
Calmar ratio
The chart of Calmar ratio for ^GSPC, currently valued at 1.35, compared to the broader market0.001.002.003.004.005.001.35
Martin ratio
The chart of Martin ratio for ^GSPC, currently valued at 6.32, compared to the broader market-30.00-20.00-10.000.0010.0020.006.32

Sharpe Ratio

The current Adaptive Biotechnologies Corporation Sharpe ratio is -0.59. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Adaptive Biotechnologies Corporation with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00FebruaryMarchAprilMayJuneJuly
-0.59
1.66
ADPT (Adaptive Biotechnologies Corporation)
Benchmark (^GSPC)

Dividends

Dividend History


Adaptive Biotechnologies Corporation doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%FebruaryMarchAprilMayJuneJuly
-93.84%
-4.24%
ADPT (Adaptive Biotechnologies Corporation)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Adaptive Biotechnologies Corporation. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Adaptive Biotechnologies Corporation was 96.55%, occurring on Apr 18, 2024. The portfolio has not yet recovered.

The current Adaptive Biotechnologies Corporation drawdown is 93.84%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-96.55%Jan 25, 2021814Apr 18, 2024
-68.3%Sep 5, 2019133Mar 16, 2020188Dec 10, 2020321
-27.29%Jul 1, 201925Aug 5, 201918Aug 29, 201943
-14.85%Dec 24, 20207Jan 5, 20217Jan 14, 202114
-2.05%Dec 15, 20201Dec 15, 20202Dec 17, 20203

Volatility

Volatility Chart

The current Adaptive Biotechnologies Corporation volatility is 18.88%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%5.00%10.00%15.00%20.00%25.00%30.00%35.00%FebruaryMarchAprilMayJuneJuly
18.88%
3.80%
ADPT (Adaptive Biotechnologies Corporation)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Adaptive Biotechnologies Corporation over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

P/E Ratio

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Adaptive Biotechnologies Corporation.


Loading data...

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items